MartinPCarrollMD

Associate Professor, Medicine, Perelman School of Medicine

Are you Dr. Carroll?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Martin Carroll, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1997
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
Geisel School of Medicine at DartmouthClass of 1988

PubMed

3500 citations
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Timothy J. Ley, Christopher A. Miller, Li Ding, Benjamin J. Raphael, Andrew J. Mungall
The New England Journal of Medicine. 2013-05-30
45 citations
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Andrew H Matthews, Alexander E Perl, Selina M Luger, Alison W Loren, Saar I Gill
Blood Advances. 2022-07-12
455 citations
CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins
Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Elisabeth Buchdunger, Jürg Zimmermann
Blood. 1997-12-15

Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 6th, 2019
Heterogeneity of Human Bone Marrow and Blood Natural Killer Cells Defined by Single-Cell TranscriptomeSeptember 2nd, 2019
Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32August 7th, 2018

Stem Cells, Differentiation And Therapeutic Resistance In AMLNational Cancer Institute2011–2012
A Phase I/II Trial Of Eltrombopag In Elderly Acute Myeloid Leukemia PatientsNational Cancer Institute2011
Core D: Xenotransplantation Mouse CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
The Role Of BCR/ABL In Regulating DNA RepairNational Cancer Institute2004–2008
Mechanisms Of Transformation By TEL PdgfbrNational Cancer Institute1998–2001
Mechanisms Of Transformation By TEL PdgfbrNational Cancer Institute1997–1998